Ergotamine tartrate

Ergotamine Tartrate can cause developmental toxicity according to state or federal government labeling requirements. Ergotamine Tartrate is the tartrate salt form of ergotamine, an ergot alkaloid and adrenergic alpha agonist with vasoconstrictor activity. Ergotamine tartrate selectively binds to alpha-adrenergic receptors thereby stimulating vascular smooth muscle and causing vasoconstriction in both arteries and veins. Ergotamine tartrate also blocks serotonin 5-HT1D receptors, thereby also causing vasoconstriction in cerebral blood vessels. Constriction of cerebral blood vessels caused by this agent may reduce the blood flow and pressure in cerebral arteries and may relieve the pain of vascular headaches. It is grouped under the following drug class(es): Vasoconstrictors. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Wigrettes, Lingran and Secupan. Its PubChem CID is 9787.

CAS No 379-79-3
Molecular Formula C70H76N10O16
Molecular Weight 1313.4 g/mol
Synonyms bis((6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide);(2R,3R)-2,3-dihydroxybutanedioic acid

Zoho Contact Form

"*" indicates required fields

I am a*
This field is for validation purposes and should be left unchanged.

Frequently Asked Questions